Recombinant EGFR/MMP-2 bi-targeted fusion protein markedly binding to non-small-cell lung carcinoma and exerting potent therapeutic efficacyJian Xu, Yong‐Su Zhen, Shenghua Zhang et al.|Pharmacological Research|2017Cited by 31
EGFR-targeting, β-defensin-tailored fusion protein exhibits high therapeutic efficacy against EGFR-expressed human carcinoma via mitochondria-mediated apoptosisWenjuan Liu, Yong‐Su Zhen, Xiujun Liu et al.|Acta Pharmacologica Sinica|2018Cited by 25
Enhancing the Therapeutic Efficacy of Gefitinib in Human Non-Small-Cell Lung Cancer through Drug CombinationMengran Zhang, Xiujun Liu, Hao Cai et al.|Molecular Pharmaceutics|2021Cited by 23
An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacyJian Xu, Yong‐Su Zhen, Xiujun Liu et al.|Oncotarget|2015Cited by 22
Intensive fibrosarcoma-binding capability of the reconstituted analog and its antitumor activityJian Xu, Yong‐Su Zhen, Yue Du et al.|Drug Delivery|2017Cited by 6